Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...

Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

In the quest for a reliable way to detect any stirrings of a sentient “I” in artificial intelligence systems, researchers are turning to one area of experience—pain—that inarguably unites ...

Our editors also may be in touch with follow-up questions. Cannabidiol (CBD) may offer numerous health benefits, including pain reduction and anxiety relief, without the intoxicatingly ...

A new type of pain medication to hit the market will create an alternative —it’s not an opioid — and could open the door to more drugs of this type in the future. CNN values your feedback 1.

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

For all the known benefits CBD offers, it’s unclear how well it can relieve nerve pain. Few studies have looked at CBD and nerve pain specifically. With neuropathy, CBD research is even more ...